9 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EP-100 (SERIES)

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

JOBST Travel Sock

FDA UDI
BSN MEDICAL, INC.·00035664013011·TRAVEL SOCKS 15-20 MM HG KNEE HIGH CLOSED TOE S...

Archon

FDA UDI
Nuvasive, Inc.·00887517078384·Archon Screw, 4.0x15mm Vari Self Tap

POROCOAT NEW JERSEY SHOULDER REPLACEMENT SYS

FDA 510(k)
FDA Class 2 ·Orthopedic

ENDOMETRIAL PIPELLE

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

PORTABLE AIR COMPRESSOR FOR MEDICAL PURPOSES

FDA Adverse Event
Malfunction ·INVACARE REHABILITATION EQUIP·Product code BTI·June 19, 2014

POWERED WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code ITI·December 22, 2012

INFUSOR LV5, 12 PK

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - IRVINE·Product code MEB·October 28, 2010

Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017